Jackson Square Partners’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-415,083
Closed -$48.1M 86
2018
Q3
$48.1M Sell
415,083
-69,820
-14% -$7.88M 0.24% 72
2018
Q2
$61.2M Sell
484,903
-2,296
-0.5% -$279K 0.31% 71
2018
Q1
$52.7M Sell
487,199
-11,748
-2% -$1.3M 0.26% 73
2017
Q4
$54.7M Buy
498,947
+37,389
+8% +$3.73M 0.28% 73
2017
Q3
$45.6M Buy
461,558
+15,404
+3% +$1.49M 0.22% 76
2017
Q2
$45.2M Sell
446,154
-135,087
-23% -$14.6M 0.23% 74
2017
Q1
$67.1M Sell
581,241
-374,215
-39% -$43.5M 0.33% 68
2016
Q4
$115M Sell
955,456
-86,596
-8% -$9.59M 0.59% 35
2016
Q3
$117M Sell
1,042,052
-382,384
-27% -$44M 0.52% 36
2016
Q2
$234M Sell
1,424,436
-72,880
-5% -$8.8M 0.98% 30
2016
Q1
$224M Sell
1,497,316
-43,270
-3% -$4.5M 0.9% 31
2015
Q4
$226M Sell
1,540,586
-155,810
-9% -$17.8M 0.84% 30
2015
Q3
$169M Sell
1,696,396
-39,725
-2% -$4.32M 0.77% 34
2015
Q2
$198M Sell
1,736,121
-478,984
-22% -$58.1M 0.76% 38
2015
Q1
$231M Buy
2,215,105
+311,988
+16% +$33.2M 0.89% 35
2014
Q4
$229M Buy
1,903,117
+429,233
+29% +$56.4M 0.9% 32
2014
Q3
$216M Buy
1,473,884
+230,285
+19% +$35.5M 0.91% 32
2014
Q2
$141M Buy
+1,243,599
New +$221M 0.55% 41

Other funds holding CLB

Jackson Square Partners's CLB Position: Q4 2018 in Review

Jackson Square Partners sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 415,083 shares — an estimated $48.1M sold.

Jackson Square Partners first reported a position in CLB in Q2 2014 and held it in 18 quarters. The position peaked at $234M in Q2 2016. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Jackson Square Partners reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Jackson Square Partners sold 415,083 Core Laboratories shares in Q4 2018, an estimated $48.1M.
  • Jackson Square Partners first reported a position in Core Laboratories in Q2 2014 and held it in 18 quarters.
  • Jackson Square Partners's Core Laboratories position peaked at $234M in Q2 2016.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Jackson Square Partners's 13F filing for Q4 2018, filed 13 Feb 2019.